Congratulations to our client CollPlant and to United Therapeutics for announcing a Global Licensing and Commercialization Agreement for 3D bioprinting of Solid-Organ Scaffolds for Human Transplants.
Mark Cohen, Senior Partner and Chair of the Life Science Practice Group, represented Collplant in its intellectual property and due diligence matters for the Transaction.
See the full announcement HERE
